Zdrowie i gospodarka · 08/11/2007

FDA Proposes Updates to Blood and Blood Component Regulations

The Food and Drug Administration (FDA) is proposing to revise its regulations for blood and blood components, including Source Plasma and Source Leukocytes, to enhance donor screening and align with industry best practices, with the goal of ensuring the safety of the national blood supply and protecting donor health.